Chemello et al. 1994. Response to ribavirin and to a combination of both in patients with chronic hepatitis C and its relation to HCV genotypes. Journal of Hepatology. vol. 21. (Suppl. 1), p. S12. Abstract No. GS 5/29.* |
Xu et al. 1998. PK/PD modeling approach to support clinical development of a long-acting interferon (RO25-3036) for the treatment of chronic hepatitis C. Clin. Pharmacol. Ther. vol. 63. No. 2, p. 162. Abstract No. Pl-101.* |
Lai, et al., Gastroenterology, Nov. 1996, vol. III, pp. 1307-1312. |
Sato, et al., NS5A Region and the Prediction of Interferon Effect, Igaku-no-Ayumi (May 3, 1997), vol. 181, (No. 5) pp. 330-340 (Translation). |
Hayashi, N., Today's Therapy, Chronic Hepatitis, Konnichi-no-Chiryo-Sisin, Jan. 15, 1997, p. 403 (Translation). |
Gunther, R., “What is Ribavirin?” and “Combination with Ribavirin for Non-Responders”, Medical Tribune, Nr 22, May 30, 1997, www.hepatitis-c.de/wasriba.htm (in German). |
Schalm, SW., et al., Digestive Diseases and Sciences, vol. 41, (No. 12) Dec. 1996, Supplement, pp. 131S to 134S. |
Reichard, O.., et al., “Interferon-Alpha and Ribavirin versus Interferon alpha as Therapy for Chronic Hepatitis C—A randomized Double-blind placebo-controlled study.” American Association for the Study of Liver Diseases, 1996 Annual Meeting, www.hepatitis-c.de/riba.htm. |
Pol, S., et al., “Ribavirin-Interferon v. Interferon alone in Non-Responders to IFN in Chronic Hepatitis C”, American Association for the Study of Liver Diseases, 1996 Annual Meeting,. www.hepatitis-c.de/riba.htm. |
Lurie, Y., et al., “Ribavirin Interferon Combination for chronic HCV”, American Gastroenterology Association Digestive Disease Week meeting in Washington, May 1997, www.hepatitis-c.de/riba.htm. |
Bellobuono, A., et al. “Ribavirin and interferon-alph combination therapy v. interferon-alpha alone in the treatment of chronic hepatitis C; A randomized clinical trial;” Journal of Viral Hepat 1997; vol. 4, 185-191. |
Weiland, et al., “Combination Treatment with Interferon Alpha-2b and Ribavirin in Patients Suffering from Chronic Hepatitis C Relapsing After, or Not Responding to Earlier Treatment with Interferon,” Translation of Abstract from Lakarstamman (Swedish Physicians' Meeting) Stockholm—Dec. 1993. |
El Zayadi, et al., “Combination treatment of alpha interferon-2b and ribavirin in chronic hepatitis C genotype”< Hepatology 22 (4 Pt 2),152A (1995). |
Bizollon, et al., “Ribavirin and interferon treatment for Hepatitis C recurrence [sic] Following Orthotopic Liver Transplantation”, Abstract, Hepatology 21 Suppl 1, p. S58 (1994). |